Madrigal Pharmaceuticals (MDGL) PT Raised to $174 at B.Riley/FBR
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Price: $516.56 +0.65%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 19
Join SI Premium – FREE
B.Riley/FBR analyst Mayank Mamtani raised the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $174.00 (from $134.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Assumes Madrigal Pharmaceuticals (MDGL) at Buy
- Meridian Mining Plc (MNO:CN) PT Raised to GBP3.75 at BMO Capital
- Slate Grocery REIT (SGR-U:CN) (SRRTF) PT Lowered to $8.75 at Scotiabank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
